ArticleImmunologic research2022

Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study.

Khalaf Kridin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.